TeraWulf stock in focus after KBW upgrade, $1.3B Texas data-center debt deal

TeraWulf stock in focus after KBW upgrade, $1.3B Texas data-center debt deal

NEW YORK, January 1, 2026, 04:18 ET — Market closed Shares of Nasdaq-listed TeraWulf Inc rose nearly 3% in the last U.S. session after Keefe, Bruyette & Woods upgraded the company and more than doubled its price target, keeping its pivot beyond bitcoin mining in focus. The stock ended Wednesday at $11.49, after ranging between $11.07 and $11.88 on volume…
Visa stock today: $500 million escrow move reshapes share conversion math as markets shut

Visa stock today: $500 million escrow move reshapes share conversion math as markets shut

NEW YORK, January 1, 2026, 04:10 ET — Market closed Visa Inc (V) said it adjusted conversion rates for its class B shares after a $500 million deposit into a U.S. litigation escrow account, a filing showed. Visa shares last closed down 0.8% at $350.71, after trading between $350.71 and $355.13; the stock has ranged from $284.20 to $374.12 over…
Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

NEW YORK, January 1, 2026, 04:13 ET — Market closed Corcept Therapeutics Incorporated shares last closed down 50.4% at $34.80 on Wednesday. Yahoo Finance The selloff followed news that the U.S. drug regulator will not approve relacorilant in its current form for an expanded use tied to a rare hormonal disorder. The decision matters now because relacorilant was the company’s…
Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

NEW YORK, January 1, 2026, 03:20 ET — Market closed Axsome Therapeutics Inc shares jumped 22.9% to $182.64 in Wednesday’s session, after touching $184.40, with about 3.1 million shares traded. The CNS drugmaker said the U.S. Food and Drug Administration accepted and granted priority review to its supplemental new drug application for AXS-05 (dextromethorphan-bupropion) — marketed as Auvelity for major…
INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

NEW YORK, January 1, 2026, 03:10 ET — Market closed Intelligent Bio Solutions Inc said late Wednesday it will raise about $10 million in a private placement, sending its shares lower in after-hours trading after a sharp rally earlier in the session. The financing lands as the micro-cap medtech company pitches a faster path to scale for its fingerprint-based drug…
Icahn Enterprises (IEP) stock ends 2025 with a pop — here’s what investors are watching next

Icahn Enterprises (IEP) stock ends 2025 with a pop — here’s what investors are watching next

NEW YORK, January 1, 2026, 03:09 ET — Market closed Icahn Enterprises’ depositary units last climbed 3.4% in the final trading session of 2025, bucking a broader year-end slide in U.S. stocks. The units settled at $7.55 on Wednesday. MarketWatch The move matters because liquidity is thin around year-end, and investors are repositioning into the first full session of 2026…
Li Auto stock in focus after December deliveries; traders eye Nio, XPeng and Tesla next

Li Auto stock in focus after December deliveries; traders eye Nio, XPeng and Tesla next

NEW YORK, January 1, 2026, 03:16 ET — Market closed Li Auto Inc (2015.HK) (LI.O) said late Wednesday it delivered 44,246 vehicles in December, as Chinese electric-vehicle makers begin publishing year-end sales tallies. Nasdaq Li Auto’s U.S.-listed shares last closed down 34 cents, or about 2%, at $16.93. U.S. equity markets are closed on Thursday for New Year’s Day, with…
Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

NEW YORK, January 1, 2026, 03:06 ET — Market closed Nike (NKE) shares ended Wednesday up 4.1% at $63.71 after Chief Executive Elliott Hill disclosed an open-market purchase of 16,388 Class B shares at about $61.10 each, a regulatory filing showed. Under Armour’s two U.S.-listed share classes fell about 3% in the same session. MarketWatch The move came in thin…
Snowflake (SNOW) stock slips under $220 into year-end close as insider sale filings surface

Snowflake (SNOW) stock slips under $220 into year-end close as insider sale filings surface

NEW YORK, December 31, 2025, 21:17 ET — Market closed Snowflake Inc. (SNOW) shares fell 1.2% on Wednesday to $219.36, leaving the stock near the low end of the day’s $218.70-$222.35 range in the final U.S. session of 2025. The move matters because Snowflake sits in a high-growth pocket of software where valuations tend to swing with rate expectations and…
DoorDash stock ends 2025 lower as Wall Street slips; New York settlement deadline nears

DoorDash stock ends 2025 lower as Wall Street slips; New York settlement deadline nears

NEW YORK, December 31, 2025, 21:13 ET — Market closed DoorDash (DASH.O) shares slipped on Wednesday, closing down 0.7% at $226.48 in the final U.S. trading session of 2025. The stock was down 0.3% at $225.88 in after-hours trading. StockAnalysis The muted move matters now because holiday-thinned volumes can amplify swings, and U.S. markets will shut on Thursday for New…

Stock Market Today

  • Indian Stock Market Slumps Over 750 Points Amid Trade Tensions and Mixed Earnings
    January 20, 2026, 2:25 AM EST. The Indian stock market plunged over 750 points in two days as the Sensex dropped below 82,745 and the Nifty 50 fell past 25,450. Key factors driving the decline include escalating US-Europe trade tensions triggered by tariff threats, uncertainty from mixed Q3 corporate earnings, heavy selling by foreign institutional investors (FIIs), and cautious sentiment among domestic investors. US President Trump's aggressive stance on Greenland and potential tariffs on European goods have heightened geopolitical risks. FIIs have offloaded more than ₹29,000 crore in January amid concerns over an India-US trade deal and currency volatility. The downturn reflects growing market unease as global trade conflicts and lackluster earnings dampen investor confidence.
Go toTop